Rg-101 in Combination With 4 Weeks of Oral Direct Acting Antiviral Therapy Achieves High Virologic Response Rates in Treatment Naïve Genotype 1 and 4 Chronic Hepatitis C Patients: Interim Results from a Randomised, Multicenter, Phase 2 Study

G. Horvath; G. Papatheodoridis; M. Fabri; M. Makara; P. Grint; M. Huang; J. Blem; E. Lombardi

doi:10.1016/s0168-8278(16)01665-2

Rg-101 in Combination With 4 Weeks of Oral Direct Acting Antiviral Therapy Achieves High Virologic Response Rates in Treatment Naïve Genotype 1 and 4 Chronic Hepatitis C Patients: Interim Results from a Randomised, Multicenter, Phase 2 Study

Journal of Hepatology ◽

10.1016/s0168-8278(16)01665-2 ◽

2016 ◽

Vol 64 (2) ◽

pp. S159 ◽

Cited By ~ 1

Author(s):

G. Horvath ◽

G. Papatheodoridis ◽

M. Fabri ◽

M. Makara ◽

P. Grint ◽

...

Keyword(s):

Chronic Hepatitis ◽

Virologic Response ◽

Phase 2 ◽

Genotype 1 ◽

Direct Acting Antiviral ◽

Multicenter Phase ◽

Phase 2 Study ◽

Treatment Naïve ◽

Direct Acting ◽

Chronic Hepatitis C Patients

Download Full-text

THU-190-Characteristics associated with sustained virologic response in chronic hepatitis C patients who received an abbreviated course of direct-acting antiviral therapy

Journal of Hepatology ◽

10.1016/s0618-8278(19)30465-7 ◽

2019 ◽

Vol 70 (1) ◽

pp. e246

Author(s):

Kirsten Vest ◽

Mei Chang ◽

Troy Kish ◽

Amy Horey ◽

Mitchell Snyder ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Antiviral Therapy ◽

Chronic Hepatitis C ◽

Sustained Virologic Response ◽

Virologic Response ◽

Direct Acting Antiviral ◽

Direct Acting ◽

Chronic Hepatitis C Patients

Download Full-text

364 - Increased Angiotensin II/Angiotensin-(1-7) Levels in Chronic Hepatitis C Patients Who had Sustained Virologic Response with Direct-Acting Antiviral Drugs Suggest their Role in the Improvement of Hepatic Fibrosis

Gastroenterology ◽

10.1016/s0016-5085(18)33625-4 ◽

2018 ◽

Vol 154 (6) ◽

pp. S-1088

Author(s):

Nicha Teeratorn ◽

Kessarin Thanapirom ◽

Sirinporn Suksawatamnuay ◽

Panarat Thaimai ◽

Sukanya Sittisomwong ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Angiotensin Ii ◽

Chronic Hepatitis C ◽

Hepatic Fibrosis ◽

Sustained Virologic Response ◽

Virologic Response ◽

Direct Acting Antiviral ◽

Direct Acting ◽

Chronic Hepatitis C Patients

Download Full-text

Open-label phase 2 study of faldaprevir, deleobuvir and ribavirin in Japanese treatment-naive patients with chronic hepatitis C virus genotype 1 infection

Hepatology Research ◽

10.1111/hepr.12535 ◽

2015 ◽

Vol 46 (3) ◽

pp. E189-E193

Author(s):

Hiroshi Yatsuhashi ◽

Nobuyoshi Kodani ◽

Hiroyuki Ugai ◽

Masao Omata

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Phase 2 ◽

Genotype 1 ◽

Virus Genotype ◽

Open Label ◽

Phase 2 Study ◽

Chronic Hepatitis C Virus ◽

Open Label Phase ◽

Treatment Naïve

Download Full-text

4 HCV SPRINT-1 FINAL RESULTS: SVR 24 FROM A PHASE 2 STUDY OF BOCEPREVIR PLUS PEGINTRON™ (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN TREATMENT- NAIVE SUBJECTS WITH GENOTYPE-1 CHRONIC HEPATITIS C

Journal of Hepatology ◽

10.1016/s0168-8278(09)60006-4 ◽

2009 ◽

Vol 50 ◽

pp. S4 ◽

Cited By ~ 49

Author(s):

P. Kwo ◽

E. Lawitz ◽

J. McCone ◽

E. Schiff ◽

J. Vierling ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Phase 2 ◽

Genotype 1 ◽

Phase 2 Study ◽

Treatment Naïve ◽

Peginterferon Alfa

Download Full-text

A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients

Journal of Hepatology ◽

10.1016/j.jhep.2005.12.011 ◽

2006 ◽

Vol 44 (4) ◽

pp. 671-678 ◽

Cited By ~ 68

Author(s):

Vincent G. Bain ◽

Kelly D. Kaita ◽

Eric M. Yoshida ◽

Mark G. Swain ◽

E. Jenny Heathcote ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Antiviral Activity ◽

Human Albumin ◽

Interferon Alfa ◽

Phase 2 ◽

Genotype 1 ◽

Phase 2 Study ◽

Chronic Hepatitis C Patients ◽

Recombinant Human Albumin

Download Full-text

15 TELAPREVIR (TVR) q8h OR q12h COMBINED WITH EITHER PEGINTERFERON (PEG-IFN, P) ALFA-2A OR ALFA-2B AND RIBAVIRIN (RBV, R) IN TREATMENT-NAÏVE GENOTYPE 1 HEPATITIS C: FINAL RESULTS OF THE RANDOMIZED, OPEN-LABEL, MULTICENTER PHASE 2 STUDY C208

Digestive and Liver Disease ◽

10.1016/s1590-8658(10)60385-4 ◽

2010 ◽

Vol 42 ◽

pp. S6-S7 ◽

Cited By ~ 2

Author(s):

M. Colombo ◽

M.G. Rumi ◽

G. Carosi ◽

M. Puoti ◽

P. Marcellin ◽

...

Keyword(s):

Hepatitis C ◽

Phase 2 ◽

Genotype 1 ◽

Open Label ◽

Multicenter Phase ◽

Phase 2 Study ◽

Treatment Naïve

Download Full-text

A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus

Value in Health ◽

10.1016/j.jval.2018.12.011 ◽

2019 ◽

Vol 22 (6) ◽

pp. 693-703 ◽

Cited By ~ 5

Author(s):

Christopher G. Fawsitt ◽

Peter Vickerman ◽

Graham Cooke ◽

Nicky J. Welton ◽

Eleanor Barnes ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Antiviral Treatment ◽

Genotype 1 ◽

Direct Acting Antiviral ◽

Effectiveness Analysis ◽

Chronic Hepatitis C Virus ◽

Treatment Naïve ◽

Direct Acting

Download Full-text

A Prospective Multicenter Phase 2 Study of FCR/BR Alternating With Ibrutinib in Treatment-naive Patients With CLL

Case Medical Research ◽

10.31525/ct1-nct03980002 ◽

2019 ◽

Author(s):

Keyword(s):

Phase 2 ◽

Multicenter Phase ◽

Phase 2 Study ◽

Treatment Naïve

Download Full-text

1170 PREDICTORS OF DAYS UNABLE TO WORK AMONG GENOTYPE 1 TREATMENT-NAIVE CHRONIC HEPATITIS C PATIENTS: POST-HOC ANALYSES OF DATA FROM PHASE 3 ADVANCE AND ILLUMINATE STUDIES

Journal of Hepatology ◽

10.1016/s0168-8278(12)61182-9 ◽

2012 ◽

Vol 56 ◽

pp. S463

Author(s):

N. Hernandez ◽

M. Vera-Llonch ◽

J. Aggarwal ◽

M. Donepudi ◽

Z. Younossi ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Phase 3 ◽

Treatment Naïve ◽

Post Hoc ◽

Chronic Hepatitis C Patients

Download Full-text

Sustained virologic response (SVR) to direct-acting antiviral (DAA) therapy in patients with chronic hepatitis C virus (HCV) infection and hepatocellular carcinoma (HCC): a systematic review and meta-analysis

Journal of Hepatology ◽

10.1016/s0168-8278(18)30733-5 ◽

2018 ◽

Vol 68 ◽

pp. S259-S260

Author(s):

F. Ji ◽

M.T. Wei ◽

Y.H. Yeo ◽

B. Wei ◽

E. Ogawa ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Systematic Review ◽

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Meta Analysis ◽

Virologic Response ◽

Direct Acting Antiviral ◽

Chronic Hepatitis C Virus ◽

Direct Acting

Download Full-text